Voyager Therapeutics, Inc. (VYGR): Price and Financial Metrics
VYGR Price/Volume Stats
| Current price | $5.36 | 52-week high | $11.72 |
| Prev. close | $5.27 | 52-week low | $5.19 |
| Day low | $5.28 | Volume | 464,300 |
| Day high | $5.59 | Avg. volume | 642,369 |
| 50-day MA | $6.57 | Dividend yield | N/A |
| 200-day MA | $7.78 | Market Cap | 292.80M |
VYGR Stock Price Chart Interactive Chart >
Voyager Therapeutics, Inc. (VYGR) Company Bio
Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. The company was founded in 2013 and is based in Cambridge, Massachusetts.
VYGR Price Returns
| 1-mo | -13.41% |
| 3-mo | -21.18% |
| 6-mo | -34.87% |
| 1-year | -22.09% |
| 3-year | 75.74% |
| 5-year | -62.41% |
| YTD | -36.49% |
| 2023 | 38.36% |
| 2022 | 125.09% |
| 2021 | -62.10% |
| 2020 | -48.75% |
| 2019 | 48.40% |
Continue Researching VYGR
Here are a few links from around the web to help you further your research on Voyager Therapeutics Inc's stock as an investment opportunity:Voyager Therapeutics Inc (VYGR) Stock Price | Nasdaq
Voyager Therapeutics Inc (VYGR) Stock Quote, History and News - Yahoo Finance
Voyager Therapeutics Inc (VYGR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...